Skip to content
TTM Q1 '26TTM Q4 '25TTM Q3 '25TTM Q2 '25TTM Q1 '25
Returns
Return on equity-14.3%-3.4pp-10.9%+3.2pp-14.1%+20.9pp-35.1%-3.7pp-31.3%+1.3pp
Return on assets-13.1%-3.0pp-10.2%+3.1pp-13.3%+19.7pp-32.9%-3.2pp-29.8%+1.2pp
Return on invested capital-21.2%-4.7pp-16.5%+9.3pp-25.8%+21.6pp-47.4%-6.2pp-41.2%+3.6pp
Liquidity
Current ratio10.7×-0.6×11.3×-1.1×12.4×+0.1×12.4×-1.5×13.9×-1.0×
Quick ratio10.7×-0.6×11.3×-1.1×12.4×+0.1×12.4×-1.5×13.9×-1.0×
Cash ratio2.4×+0.5×1.9×-2.7×4.6×+2.6×2.1×-0.5×2.6×+0.7×
Leverage
Debt-to-equity0.0×0.0×0.0×0.0×0.0×
Debt-to-assets0.0×0.0×0.0×0.0×0.0×
Per Share
Book value per share$10.57-8.6%$11.56-5.1%$12.18+12.2%$10.85-6.4%$11.59-10.6%
Valuation
Market capitalization$2.93B-3.5%$3.03B+27.1%$2.38B+25.0%$1.91B+33.0%$1.43B-35.4%
Enterprise value$2.8B-5.0%$2.95B+39.4%$2.11B+16.1%$1.82B+36.8%$1.33B-38.3%
Price / book3.1×+0.2×+0.8×2.2×+0.2×+0.6×1.4×-0.7×
Free cash flow yield-3%-0.6pp-2.4%+2.0pp-4.4%+11.2pp-15.6%+3.1pp-18.7%-7.4pp
Earnings yield-4.8%-1.0pp-3.8%+3.0pp-6.7%+10.7pp-17.4%+4.0pp-21.4%-9.1pp

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

Where do IDEAYA Biosciences, Inc.'s ratios come from?
Every ratio is computed from IDEAYA Biosciences, Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.